Is Monkeypox a Scapegoat for Covid Vaccine Adverse Events? Dr. Peter McCullough

"We’ve Seen this Before But You Never Heard About It"

By Zach Heilman
Global Research, May 27, 2022
Red Voice Media 26 May 2022
Region:
Theme: ,

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram, Twitter and Facebook. Feel free to repost and share widely Global Research articles.

***

Although the Biden administration hasn’t given up on defeating COVID-19 as they continue to ask for more funding for testing and the COVID-19 drug, another disease is starting to capture the media’s attention as numerous cases of monkeypox have been reported. With President Joe Biden stating that people should be concerned, many are worried that the disease might bring a new wave of restrictions, protocols, and mandates that were seen during the COVID-19 pandemic. While no announcement has been made, recently, Maria Zeee sat down with both Dr. Peter McCullough and author John Leake who suggested monkeypox might be a scapegoat for the cluster of side effects reported from the COVID-19 jab.

In the video featured below, Zee presented just a few of the side effects being seen from monkeypox. “The [monkeypox] illness begins with symptoms of fever, headache, muscle aches, swollen lymph nodes, chills, and exhaustion…. symptoms that really are just the flu…” Being interrupted, Dr. McCullough noted that the symptoms might actually be from the COVID-19 drug other than the disease.

Adding his input, Leake revealed that monkeypox isn’t new, and the United States even had an outbreak back in 2003, and nobody knew about it.

“We had a monkeypox outbreak, a small one that was quickly contained in the United States in 2003. No one even remembers it. Most people didn’t even know it was happening at the time. Seventy people got monkeypox in the United States, but it’s very identifiable. It’s grotesquely symptomatic. These people were treated and kept at home. And that was the end of it.”

Again, Dr. McCullough focused on if there was a link between the disease, side effects, and the COVID-19 drug.

“And that’s the setup [COVID shot or infection] for a relatively innocuous adenovirus 41 to cause hepatitis. Now bring in monkeypox. Is it conceivable that mass vaccination now is allowing outbreaks of other contagious viral illnesses? I think it is. Obviously, for each case, we need to know: did they take one of the COVID-19 products?”

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, Twitter and Facebook. Feel free to repost and share widely Global Research articles.

Featured image is from Red Voice Media
Articles by: Zach Heilman

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]